{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,7]],"date-time":"2026-01-07T18:31:25Z","timestamp":1767810685868,"version":"3.49.0"},"reference-count":31,"publisher":"Oxford University Press (OUP)","issue":"1","license":[{"start":{"date-parts":[[2025,12,15]],"date-time":"2025-12-15T00:00:00Z","timestamp":1765756800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,1,6]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Aims<\/jats:title>\n                    <jats:p>There is limited evidence regarding the association between chronic liver disease (CLD) and the risk of readmission in patients with heart failure (HF).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods and results<\/jats:title>\n                    <jats:p>We utilized data from the 2019 Nationwide Readmissions Database (NRD). An index hospitalization was defined as a hospitalization for HF among patients aged \u226518 years with an alive discharge. We categorized patients into two groups, with and without CLD, and compared 30-day and 90-day all-cause and HF-specific readmission. Multiple logistic regression analyses were used to estimate the association between CLD and readmissions in HF patients, adjusting for demographic and clinical characteristics. We also evaluated the association between specific CLD subtypes [i.e. hepatitis B (HBV), hepatitis C (HCV), alcoholic liver disease (ALD), and metabolic dysfunction-associated steatotic liver disease (MASLD)] and the risk of readmission. The study included 2 370 469 index HF hospitalizations for the 30-day analysis and 2 090 370 for the 90-day analysis. CLD patients had higher 30-day all-cause [adjusted odds ratio (aOR) 1.20 (1.18\u20131.23)] and HF-specific [aOR 1.16 (1.14\u20131.19)] readmission rates compared with those without CLD. Similar findings were observed for 90-day all-cause [aOR 1.19 (1.17\u20131.21)] and HF-specific [aOR 1.13 (1.11\u20131.16)] readmissions. Results were consistent when comparing patients with and without HBV, HCV, and ALD, with no meaningful differences observed between those with and without MASLD.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Compared with HF patients without CLD, those with CLD had a higher risk of 30- and 90-day readmissions, underscoring the importance of accounting for CLD in the risk assessment and clinical decision-making for HF patients.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/ehjopen\/oeaf168","type":"journal-article","created":{"date-parts":[[2025,12,9]],"date-time":"2025-12-09T12:58:53Z","timestamp":1765285133000},"source":"Crossref","is-referenced-by-count":0,"title":["Chronic liver disease is associated with greater risk of hospital readmission in patients with heart failure: a nationwide database study in the US"],"prefix":"10.1093","volume":"6","author":[{"given":"Hung-Kai","family":"Chen","sequence":"first","affiliation":[{"name":"Department of Pharmaceutical Outcomes and Policy, University of Florida Malachowsky Hall, 1889 Museum Rd Suite 6300, Gainesville, FL 32603 ,","place":["USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julia","family":"Yang","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Outcomes and Policy, University of Florida Malachowsky Hall, 1889 Museum Rd Suite 6300, Gainesville, FL 32603 ,","place":["USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jabed Al","family":"Faysal","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Outcomes and Policy, University of Florida Malachowsky Hall, 1889 Museum Rd Suite 6300, Gainesville, FL 32603 ,","place":["USA"]},{"name":"Computer Science and Engineering Discipline, Khulna University \u00a0 Gollamari, Khulna-9208, Bangladesh"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jingchuan","family":"Guo","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Outcomes and Policy, University of Florida Malachowsky Hall, 1889 Museum Rd Suite 6300, Gainesville, FL 32603 ,","place":["USA"]},{"name":"Department of Pharmacy Practice, Purdue University College of Pharmacy \u00a0 Fifth Third Bank Building at Eskenazi Health, 640 Eskenazi Ave, Indianapolis, IN 46202 ,","place":["USA"]},{"name":"Regenstrief Institute , 1101 W 10th St, Indianapolis, IN 46202 ,","place":["USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2025,12,15]]},"reference":[{"key":"2026010712354714900_oeaf168-B1","doi-asserted-by":"crossref","first-page":"e139","DOI":"10.1161\/CIR.0000000000000757","article-title":"Heart disease and stroke statistics-2020 update: a report from the American Heart Association","volume":"141","author":"Virani","year":"2020","journal-title":"Circulation"},{"key":"2026010712354714900_oeaf168-B2","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1161\/HHF.0b013e318291329a","article-title":"Forecasting the impact of heart failure in the United States: a policy statement from the American Heart Association","volume":"6","author":"Heidenreich","year":"2013","journal-title":"Circ Heart Fail"},{"key":"2026010712354714900_oeaf168-B3","doi-asserted-by":"crossref","first-page":"e1932","DOI":"10.7205\/MILMED-D-17-00017","article-title":"Repeat hospitalizations predict mortality in patients with heart failure","volume":"182","author":"Lin","year":"2017","journal-title":"Mil Med"},{"key":"2026010712354714900_oeaf168-B4","doi-asserted-by":"crossref","first-page":"e008335","DOI":"10.1161\/CIRCHEARTFAILURE.121.008335","article-title":"Trends in 30- and 90-day readmission rates for heart failure","volume":"14","author":"Khan","year":"2021","journal-title":"Circ Heart Fail"},{"key":"2026010712354714900_oeaf168-B5","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.jchf.2018.10.007","article-title":"Heart failure and liver disease: cardiohepatic interactions","volume":"7","author":"Xanthopoulos","year":"2019","journal-title":"JACC Heart Fail"},{"key":"2026010712354714900_oeaf168-B6","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1007\/s40273-020-00952-0","article-title":"A systematic review of medical costs associated with heart failure in the USA (2014\u20132020)","volume":"38","author":"Urbich","year":"2020","journal-title":"Pharmacoeconomics"},{"key":"2026010712354714900_oeaf168-B7","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1038\/cmi.2016.3","article-title":"Liver immunology and its role in inflammation and homeostasis","volume":"13","author":"Robinson","year":"2016","journal-title":"Cell Mol Immunol"},{"key":"2026010712354714900_oeaf168-B8","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1016\/j.jhep.2023.05.046","article-title":"Liver disease is a significant risk factor for cardiovascular outcomes\u2014a UK Biobank study","volume":"79","author":"Roca-Fernandez","year":"2023","journal-title":"J Hepatol"},{"key":"2026010712354714900_oeaf168-B9","doi-asserted-by":"crossref","first-page":"1332557","DOI":"10.3389\/fcvm.2024.1332557","article-title":"Mendelian randomization of chronic hepatitis B and cardiovascular disease","volume":"11","author":"Wu","year":"2024","journal-title":"Front Cardiovasc Med"},{"key":"2026010712354714900_oeaf168-B10","doi-asserted-by":"crossref","first-page":"Cr587","DOI":"10.12659\/MSM.883356","article-title":"Effect of hepatitis B virus infection on right and left ventricular functions","volume":"18","author":"Demir","year":"2012","journal-title":"Med Sci Monit"},{"key":"2026010712354714900_oeaf168-B11","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1086\/599371","article-title":"Hepatitis C virus infection and the risk of coronary disease","volume":"49","author":"Butt","year":"2009","journal-title":"Clin Infect Dis"},{"key":"2026010712354714900_oeaf168-B12","doi-asserted-by":"crossref","first-page":"e021654","DOI":"10.1161\/JAHA.121.021654","article-title":"Nonalcoholic fatty liver disease and risk of heart failure among medicare beneficiaries","volume":"10","author":"Fudim","year":"2021","journal-title":"J Am Heart Assoc"},{"key":"2026010712354714900_oeaf168-B13","doi-asserted-by":"crossref","first-page":"e024890","DOI":"10.1161\/JAHA.121.024890","article-title":"Trends, predictors, and outcomes of 30-day readmission with heart failure after transcatheter aortic valve replacement: insights from the US nationwide readmission database","volume":"11","author":"Zahid","year":"2022","journal-title":"J Am Heart Assoc"},{"key":"2026010712354714900_oeaf168-B14","doi-asserted-by":"crossref","first-page":"1929","DOI":"10.1053\/j.gastro.2020.02.020","article-title":"Metabolic inflammation\u2014A role for hepatic inflammatory pathways as drivers of comorbidities in nonalcoholic fatty liver disease?","volume":"158","author":"Gehrke","year":"2020","journal-title":"Gastroenterology"},{"key":"2026010712354714900_oeaf168-B15","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1007\/s00011-006-0082-0","article-title":"Toll-like receptor expression in chronic hepatitis C: correlation with pro-inflammatory cytokine levels and liver injury","volume":"55","author":"Riordan","year":"2006","journal-title":"Inflamm Res"},{"key":"2026010712354714900_oeaf168-B16","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1590\/S0100-879X2005000500017","article-title":"Effect of hepatitis C serology on C-reactive protein in a cohort of Brazilian hemodialysis patients","volume":"38","author":"Nascimento","year":"2005","journal-title":"Braz J Med Biol Res"},{"key":"2026010712354714900_oeaf168-B17","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1038\/nature01323","article-title":"Inflammation in atherosclerosis","volume":"420","author":"Libby","year":"2002","journal-title":"Nature"},{"key":"2026010712354714900_oeaf168-B18","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1038\/nri1882","article-title":"The immune response in atherosclerosis: a double-edged sword","volume":"6","author":"Hansson","year":"2006","journal-title":"Nat Rev Immunol"},{"key":"2026010712354714900_oeaf168-B19","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1056\/NEJMra043430","article-title":"Inflammation, atherosclerosis, and coronary artery disease","volume":"352","author":"Hansson","year":"2005","journal-title":"N Engl J Med"},{"key":"2026010712354714900_oeaf168-B20","doi-asserted-by":"crossref","first-page":"63","DOI":"10.5551\/jat.10.63","article-title":"Inflammatory reactions in the pathogenesis of atherosclerosis","volume":"10","author":"Fan","year":"2003","journal-title":"J Atheroscler Thromb"},{"key":"2026010712354714900_oeaf168-B21","doi-asserted-by":"crossref","first-page":"e0173398","DOI":"10.1371\/journal.pone.0173398","article-title":"Nonalcoholic fatty liver disease and increased risk of 1-year all-cause and cardiac hospital readmissions in elderly patients admitted for acute heart failure","volume":"12","author":"Valbusa","year":"2017","journal-title":"PLoS One"},{"key":"2026010712354714900_oeaf168-B22","doi-asserted-by":"crossref","first-page":"100993","DOI":"10.1016\/j.cpcardiol.2021.100993","article-title":"Association between cirrhosis and 30-day rehospitalization after Index hospitalization for heart failure","volume":"47","author":"Yazdanyar","year":"2022","journal-title":"Curr Probl Cardiol"},{"key":"2026010712354714900_oeaf168-B23","volume-title":"Healthcare Cost and Utilization Project (HCUP)","author":"NRD Overview","year":"2024"},{"key":"2026010712354714900_oeaf168-B24","doi-asserted-by":"crossref","first-page":"101108","DOI":"10.1016\/j.aohep.2023.101108","article-title":"Non-alcoholic fatty liver disease is associated with greater risk of 30-day hospital readmission in the United States (U.S.)","volume":"28","author":"Paik","year":"2023","journal-title":"Ann Hepatol"},{"key":"2026010712354714900_oeaf168-B25"},{"key":"2026010712354714900_oeaf168-B26","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1111\/j.1532-5415.1990.tb03450.x","article-title":"Early readmission of elderly patients with congestive heart failure","volume":"38","author":"Vinson","year":"1990","journal-title":"J Am Geriatr Soc"},{"key":"2026010712354714900_oeaf168-B27","doi-asserted-by":"crossref","first-page":"3227","DOI":"10.1093\/eurheartj\/ehab484","article-title":"2021 ESC guidelines on cardiovascular disease prevention in clinical practice","volume":"42","author":"Visseren","year":"2021","journal-title":"Eur Heart J"},{"key":"2026010712354714900_oeaf168-B28","doi-asserted-by":"crossref","first-page":"3627","DOI":"10.1093\/eurheartj\/ehad195","article-title":"2023 focused update of the 2021 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure","volume":"44","author":"McDonagh","year":"2023","journal-title":"Eur Heart J"},{"key":"2026010712354714900_oeaf168-B29","first-page":"e895","article-title":"2022 AHA\/ACC\/HFSA guideline for the management of heart failure: a report of the American College of Cardiology\/American Heart Association joint committee on clinical practice guidelines","volume":"145","author":"Heidenreich","year":"2022","journal-title":"Circulation"},{"key":"2026010712354714900_oeaf168-B30","doi-asserted-by":"crossref","first-page":"e009078","DOI":"10.1161\/CIRCOUTCOMES.122.009078","article-title":"Validity of international classification of diseases (ICD)-10 diagnosis codes for identification of acute heart failure hospitalization and heart failure with reduced versus preserved ejection fraction in a national medicare sample","volume":"16","author":"Bates","year":"2023","journal-title":"Circ Cardiovasc Qual Outcomes"},{"key":"2026010712354714900_oeaf168-B31","doi-asserted-by":"crossref","first-page":"2107","DOI":"10.1007\/s10620-021-07076-1","article-title":"International classification of diseases codes are useful in identifying cirrhosis in administrative databases","volume":"67","author":"Dahiya","year":"2022","journal-title":"Dig Dis Sci"}],"container-title":["European Heart Journal Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ehjopen\/advance-article-pdf\/doi\/10.1093\/ehjopen\/oeaf168\/65885373\/oeaf168.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ehjopen\/article-pdf\/6\/1\/oeaf168\/65885373\/oeaf168.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ehjopen\/article-pdf\/6\/1\/oeaf168\/65885373\/oeaf168.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,7]],"date-time":"2026-01-07T17:35:55Z","timestamp":1767807355000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ehjopen\/article\/doi\/10.1093\/ehjopen\/oeaf168\/8380280"}},"subtitle":[],"editor":[{"given":"Nicolas","family":"Girerd","sequence":"additional","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2025,12,15]]},"references-count":31,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1,6]]}},"URL":"https:\/\/doi.org\/10.1093\/ehjopen\/oeaf168","relation":{},"ISSN":["2752-4191"],"issn-type":[{"value":"2752-4191","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,1]]},"published":{"date-parts":[[2025,12,15]]},"article-number":"oeaf168"}}